T. Krieg

A disease severity scale for systemic sclerosis: development and testing.

Thomas A. Medsger, Alan J. Silman, Virginia Steen et al. · PubMed · 1999 · 444 citations

Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures.

Manfred Wiestner, T. Krieg, D Hörlein et al. · Journal of Biological Chemistry · 1979 · 255 citations · Full text

Tissue Engineering, Engineering, Collagen Biosynthesis +20

Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.

Martina Kulozik, Annette Hogg, Brigitte Lankat–Buttgereit et al. · Journal of Clinical Investigation · 1990 · 219 citations · Full text

Sclerostin, Immunology, Pathology +20

Tissue Inhibitor of Matrix Metalloproteinase-2 Regulates Matrix Metalloproteinase-2 Activation by Modulation of Membrane-type 1 Matrix Metalloproteinase Activity in High and Low Invasive Melanoma Cell Lines

Peter Kurschat, Paola Zigrino, Roswitha Nischt et al. · Journal of Biological Chemistry · 1999 · 152 citations · Full text

Melanoma Cell Lines, Matrix Metalloproteinase Activity, Melanoma +15

Expression of TGF-β1, -β2 and -β3 in localized and systemic scleroderma

Christiane Querfeld, Beate Eckes, Christina Huerkamp et al. · Journal of Dermatological Science · 1999 · 101 citations

Sclerostin, Systemic Scleroderma, Pathology +4